Related references
Note: Only part of the references are listed.A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism
Eva Morava et al.
BRAIN (2010)
SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder
Vincent Cantagrel et al.
CELL (2010)
Metabolic manipulation of glycosylation disorders in humans and animal models
Hudson H. Freeze et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib
P. de Lonlay et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
CDG nomenclature: Time for a change!
Jaak Jaeken et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)
Stephanie Grunewald
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Congenital Disorders of Glycosylation: An Update on Defects Affecting the Biosynthesis of Dolichol-Linked Oligosaccharides
Micha A. Haeuptle et al.
HUMAN MUTATION (2009)
Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc
Sviatlana Yakubenia et al.
BLOOD (2008)
Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis -: A link to ceramide synthase-3
Mariona Rabionet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II
Christina C. Hellbusch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality
Christian Thiel et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Essential and mutually compensatory roles of α-mannosidase II and α-mannosidase IIx in N-glycan processing in vivo in mice
Tomoya O. Akama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality
C DeRossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
N-glycan branching requirement in neuronal and postnatal viability
ZY Ye et al.
GLYCOBIOLOGY (2004)
Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij
XH Wu et al.
HUMAN MUTATION (2003)
Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene
A Hidalgo et al.
BLOOD (2003)
Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:: α-6-D-mannoside β1,2-N-acetylglucosaminyltransferase II:: a model for congenital disorder of glycosylation type IIa
Y Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Congenital disorder of glycosylation IId (CDG-IId) -: A new entity:: Clinical presentation with Dandy-Walker malformation and myopathy
V Peters et al.
NEUROPEDIATRICS (2002)
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis
Y Wang et al.
GLYCOBIOLOGY (2001)
Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism
V Cormier-Daire et al.
JOURNAL OF MEDICAL GENETICS (2000)
Share Paper
